Dublin, March 05, 2018 -- The "Chemical Licensing Market by Type (C1 Derivatives, C2 Derivatives, C3 Derivatives, C4 Derivatives) End-Use Industry (Oil & Gas, Chemical) & Region (North America, Europe, Asia-Pacific, Middle East & Africa, South America) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The Chemical Licensing Market is Estimated to Be USD 10.72 Billion in 2017 and is Projected to Reach USD 13.81 Billion By 2022, at a CAGR of 5.2% from 2017 to 2022.
The increasing population, expanding manufacturing industry, and growing regulatory requirements in the chemical industry are key factors projected to drive the growth of the chemical licensing market. However, the limited adoption of chemical licensing in emerging economies, owing to the high costs of technologies, acts as a restraint to the growth of the market.
Based on end-use industry, the chemical segment is projected to grow at the highest CAGR during the forecast period. Chemical licensing caters to various industries including the base chemical, active pharmaceutical ingredient, specialty chemical, and polymer industries.
Chemical manufacturers that require C1, C2, C3, and other hydrocarbon derivatives are focused on backward integration by producing these chemicals and providing the licensing for the same, and hence need licenses to produce C1, C2, C3, and other derivatives. The global growth in industrial output is boosting the growth of the chemical industry market, which in turn, is expected to drive the growth of the chemical licensing market during the forecast period.
Based on type, the C3 segment is projected to grow at the highest CAGR from 2017 to 2022. Manufacturing C3 derivatives involves polymerization, oxidation, esterification, chlorohydrogenation, saponification, hydration, epoxidation, and oxo reaction. The demand for C3 derivatives such as polypropylene, acrylonitrile, hydrogen cyanide, acrolein, acrylic ester, and propylene oxide is increasing from end-use industries, thereby propelling the need for chemical licensing in this segment.
Market Dynamics
Drivers
- Increasing Demand for Petrochemicals in APAC
- Stringent Environmental Regulations
- Cost Optimization Strategies Implemented By Refiners
Restraints
- In-House Technology Development By End Users
Opportunities
- Increasing Refinery Capacities
- Increasing Use of New Technologies for Sustainable Manufacturing
Challenges
- Cost Optimization and High Licensing Cost
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Chemical Licensing Market, By Type
8 Chemical Licensing Market, By End-Use Industry
9 Chemical Licensing Market, By Region
10 Competitive Landscape
11 Company Profiles
- Chevron Phillips Chemical Company
- Eastman Chemical Company
- Exxon Mobil Corporation
- Huntsman Corporation
- Johnson Matthey
- Mitsubishi Chemical Corporation
- Mitsui Chemicals, Inc.
- Nova Chemicals Corporation
- Shell Global Solutions
- Sumitomo Chemical
For more information about this report visit https://www.researchandmarkets.com/research/hksh9w/global_chemical?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Chemicals


Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
DeepSeek to Raise AI API Prices as Demand for New Models Surges
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 



